
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 13.850 | 13.850 | 0.000 |
Shares | 86.470 | 86.470 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.872 | 22.347 |
Price to Book | 2.822 | 2.714 |
Price to Sales | 2.680 | 3.330 |
Price to Cash Flow | 15.759 | 16.400 |
Dividend Yield | 2.833 | 2.102 |
5 Years Earnings Growth | 6.759 | 6.822 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 98.630 | 97.797 |
Consumer Defensive | 1.160 | 1.757 |
Basic Materials | 0.180 | 0.472 |
Technology | 0.020 | 0.380 |
Industrials | 0.010 | 0.563 |
Number of long holdings: 84
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Jiangsu Hengrui | CNE0000014W7 | 9.52 | 53.80 | -0.15% | |
Kelun Pharm A | CNE100000PW7 | 5.65 | 37.47 | -0.74% | |
Dong-E E-Jiao A | CNE0000006Y9 | 5.03 | 54.93 | +0.60% | |
Cr Sanjiu A | CNE0000011K8 | 4.81 | 32.69 | -1.71% | |
Huadong Med A | CNE0000011S1 | 4.73 | 43.08 | -1.33% | |
Beigene | CNE100005XT6 | 4.40 | 235.69 | +0.06% | |
Salubris Pharm A | CNE100000FW8 | 4.38 | 47.03 | +0.97% | |
KPC Pharm | CNE0000015P8 | 4.04 | 15.47 | +0.39% | |
Yuyue Medical A | CNE1000009X3 | 3.85 | 37.13 | +0.19% | |
WuXi AppTec | CNE1000031K4 | 3.63 | 64.00 | -0.74% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ICBC Credit Literary Ids Eq | 5.54B | 7.13 | 2.03 | - | ||
ICBCCS Innovation Power Eq | 4.7B | -4.40 | 6.50 | -5.49 | ||
ICBCCS China Core Value Mixed A | 3.95B | -4.35 | -5.93 | -0.13 | ||
ICBCCS MedicalHlth Care Sect Secs I | 2.72B | 16.41 | -3.31 | 1.39 | ||
ICBC Credit Net plus Eq | 2.34B | -5.67 | -8.23 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review